An underlying collagen vascular disorder was suspected, and genetic testing revealed a mutation in the collagen type III, α1 (COL3A1) gene, which is consistent with a diagnosis of Ehlers-Danlos syndrome type IV. This evidence concerns the gene COL3A1 and Ehlers-Danlos syndrome, vascular type.